Nisaurrahmah, N., Sri, O., & Ifora, I. (2021). Efficacy and Safety of 5-Hydroxytryptamine-3 Receptor Antagonists (5-HT3 RAs) for The Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Review. Journal of Drug Delivery and Therapeutics, 11(1-s), 195-199. https://doi.org/10.22270/jddt.v11i1-s.4554